Search the Newsreel

Handelsbanken Fonder AB Sells 444,592 Shares of Abbott Laboratories $ABT

Handelsbanken Fonder AB reduced its stake in Abbott Laboratories by 37.6% in the second quarter, selling 444,592 shares and retaining 736,804 shares valued at approximately $66.9 million. Abbott Laboratories reported strong quarterly results, exceeding analyst expectations with $12.59 billion in revenue and adjusted earnings …

Wheaton Precious Metals (NYSE:WPM) Shows High-Growth Leadership and Momentum

Sapient Capital LLC Sells 262,550 Shares of Kratos Defense & Security Solutions, Inc. $KTOS

Sapient Capital LLC significantly reduced its stake in Kratos Defense & Security Solutions (NASDAQ:KTOS) by 94% in the second quarter, selling 262,550 shares and retaining 16,866 shares. This divestment occurred despite Kratos reporting stronger-than-expected quarterly earnings and revenue. The stock currently holds a "Moderate …

Singapore okays Texas Instruments' $7.5B acquisition of Silicon Labs, amid fragmented global market

Singapore's Competition and Consumer Commission has approved Texas Instruments' proposed $7.5 billion acquisition of Silicon Laboratories. The commission determined that the deal would not significantly lessen competition in Singapore or globally, as the two companies are not close competitors and operate in a fragmented …

Abbott Laboratories (ABT) Just Gave Investors Something To Think About

Abbott Laboratories (ABT) recently exceeded quarterly estimates and increased its annual profit forecast, driven by strong performance in cancer diagnostics and medical devices. The company's stock has shown a significant short-term rebound, up 28.77% over 90 days, despite being down over the past year. …

Defender Capital LLC. Buys Shares of 295,450 Atomera Incorporated $ATOM

Defender Capital LLC. recently acquired 295,450 shares of Atomera Incorporated (NASDAQ:ATOM) worth approximately $2.57 million, representing a 0.76% stake in the company. Despite other institutional investors also increasing their holdings, Atomera's latest quarterly results showed a loss of $0.17 per share, missing consensus estimates, …

Valiant Lab Standalone June 2026 Net Sales at Rs 73.42 crore, up 43.94% Y-o-Y

Valiant Laboratories Shares Hit 5% Upper Circuit After Board Approves ₹60 Cr Investment in Subsidiary

Wheaton Precious Metals Corp. Is Maintained at Outperform by National Bank

National Bank has reiterated its "Outperform" rating on Wheaton Precious Metals Corp. This indicates a positive outlook from the bank regarding the company's stock performance.

Ind-Swift Laboratories Ltd leads gainers in 'B' group

Silicon Laboratories (SLAB) Earnings Date and Reports 2026 $SLAB

Dr Reddy's Laboratories Shares Rise 2.24%

Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages

Charles River Laboratories International (NYSE:CRL) has received an average "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $255.65. This follows the company exceeding quarterly earnings expectations with an adjusted EPS of $3.02 and revenue of $1.0 billion. Despite recent …

Ipca Laboratories Shares Rise 2.33% to Rs 1,725.00

Eaton Corporation, PLC (NYSE:ETN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Eaton Corporation, PLC (NYSE:ETN) has received a "Moderate Buy" consensus rating from twenty brokerages, with an average one-year price target of $431.78. The company recently reported strong quarterly results, exceeding EPS and revenue expectations, and provided optimistic guidance for the third quarter and full …

Valiant Laboratories approves ₹60 crore VASPL investment

Press Release: Mesa Labs Announces First Quarter Results

This is a press release from Mesa Labs announcing their first-quarter results. The document provided was empty, so no further summary can be generated.

Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Mesa Laboratories Inc. (MLAB) reported its Q1 2027 earnings, showing a 1% increase in total revenue to $60.1 million and a significant 16.5% rise in adjusted operating income. The company achieved margin expansion and reduced its net leverage ratio to 1.85x by repaying $8.7 …

Valiant Laboratories consolidated net profit rises 1059.34% in the June 2026 quarter

Weekly Recap: Q2 net loss, financing and (Z)-endoxifen Phase 2 progress

Atossa Therapeutics (NASDAQ:ATOS) reported a Q2 2026 net loss of $8.5M but holds $26.1M in cash. The company secured $4.5M upfront in a direct offering, with potential for up to $16.5M, and is advancing its (Z)-endoxifen program through four Phase 2 trials, expecting data …

Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What Stevanato Group's latest earnings and guidance mean for investors Stevanato Group (STVN) has …

Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028

Earnings Call Insights: Mesa Laboratories (MLAB) Q1 2027 MANAGEMENT VIEW * CEO Siddhartha Kadia framed his first call around execution fixes and capital allocation, saying, "Mesa is a set of durable, regulation embedded franchises with real and growing earnings power that had fixable execution …

Energisa Mato Grosso Distribuidora de Energia SA (BSP:ENMT3) (Q2 2026) Earnings Call ...

This article first appeared on GuruFocus. Recurring Adjusted EBITDA: Reached $1.99 billion, up 1.4% year-over-year. Recurring Adjusted Net Income: Totaled $88 million in the quarter, down 80% compared to the second quarter of '25. Net Debt: Reached $32.5 billion at the end of June. …

Atmos Energy Earnings Call Highlights Growth Momentum

Key Points Interested in Atmos Energy Corporation? Here are five stocks we like better. Atmos Energy reaffirmed its fiscal 2026 EPS guidance of $8.40–$8.50 after reporting $7.33 per diluted share for the first nine months, up 14.5% year over year. APT pipeline spreads narrowed …

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

Mesa Laboratories (MLAB) Releases Q1 2027 Earnings: Revenue Growth but EPS Declines

Kratos Defense & Security Solutions (NASDAQ:KTOS) Stock Price Up 2.7% - Here's Why

Kratos Defense & Security Solutions (NASDAQ:KTOS) saw its stock price rise 2.7% on Monday, trading at $62.42 with slightly above-average volume. This surge follows a strong quarterly performance where the company exceeded EPS and revenue estimates, with revenue growing 30.5% year-over-year. Despite a consensus …

Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss

Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …

Mesa Laboratories Inc /Co/ 2026: Revenue $60.14M, EPS $0.49— 10-Q Summary

Mesa Laboratories Inc /Co/ reported its 2026 quarterly results with revenue slightly up to $60.14M from $59.54M the previous year. However, net income decreased by 40.3% to $2.83M, and diluted EPS fell by 42.4% to $0.49. The company highlighted revenue growth in Calibration Solutions …

Mesa Laboratories (MLAB) lifts Q1 margins and cash flow while net income falls

Mesa Laboratories (MLAB) reported Q1 FY2027 revenue of $60,138, a 1.0% increase year-over-year, with gross profit rising to $39,012 due to improved gross margins. Operating income more than doubled to $7,031, and operating cash flow strengthened significantly to $14,736, leading to a net debt …

Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …

Is Mesa Laboratories Inc (MLAB) Undervalued After Q1 Earnings Mi

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDEXX Laboratories Inc. (IDXX) saw its stock rally by 1.55% to $595.76 on Monday, performing strongly despite an overall poor trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both experienced declines. IDEXX Laboratories Inc. is currently trading …

Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options

Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …

Wheaton Precious Metals Corp. stock falls Monday, underperforms market

Wheaton Precious Metals Corp. (WPM) saw its stock fall by 0.84% to C$185.75 on Monday, underperforming the Canadian market as the S&P/TSX Composite Index rose 0.21%. The company's shares closed 18.1% below their 52-week high of C$226.68, which was reached on March 2nd. This …